BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15831442)

  • 1. Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke.
    Miyata N; Seki T; Tanaka Y; Omura T; Taniguchi K; Doi M; Bandou K; Kametani S; Sato M; Okuyama S; Cambj-Sapunar L; Harder DR; Roman RJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):77-85. PubMed ID: 15831442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 20-HETE inhibition on infarct volume and cerebral blood flow after transient middle cerebral artery occlusion.
    Renic M; Klaus JA; Omura T; Kawashima N; Onishi M; Miyata N; Koehler RC; Harder DR; Roman RJ
    J Cereb Blood Flow Metab; 2009 Mar; 29(3):629-39. PubMed ID: 19107134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of delayed vasospasm by an inhibitor of the synthesis of 20-HETE.
    Takeuchi K; Renic M; Bohman QC; Harder DR; Miyata N; Roman RJ
    Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H2203-11. PubMed ID: 15964920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of delayed vasospasm by TS-011 in the dual hemorrhage dog model of subarachnoid hemorrhage.
    Hacein-Bey L; Harder DR; Meier HT; Varelas PN; Miyata N; Lauer KK; Cusick JF; Roman RJ
    AJNR Am J Neuroradiol; 2006; 27(6):1350-4. PubMed ID: 16775295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats.
    Dunn KM; Renic M; Flasch AK; Harder DR; Falck J; Roman RJ
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2455-65. PubMed ID: 18952718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous inhibition of 20-HETE synthesis by TS-011 improves neurological and functional outcomes after transient focal cerebral ischemia in rats.
    Tanaka Y; Omura T; Fukasawa M; Horiuchi N; Miyata N; Minagawa T; Yoshida S; Nakaike S
    Neurosci Res; 2007 Dec; 59(4):475-80. PubMed ID: 17933409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a new inhibitor of the synthesis of 20-HETE on cerebral ischemia reperfusion injury.
    Omura T; Tanaka Y; Miyata N; Koizumi C; Sakurai T; Fukasawa M; Hachiuma K; Minagawa T; Susumu T; Yoshida S; Nakaike S; Okuyama S; Harder DR; Roman RJ
    Stroke; 2006 May; 37(5):1307-13. PubMed ID: 16601220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inhibitor of 20-HETE synthesis, TS-011, improves cerebral microcirculatory autoregulation impaired by middle cerebral artery occlusion in mice.
    Marumo T; Eto K; Wake H; Omura T; Nabekura J
    Br J Pharmacol; 2010 Nov; 161(6):1391-402. PubMed ID: 20735406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin, NO, and 20-HETE interactions in mediating cerebral vasoconstriction following SAH.
    Takeuchi K; Miyata N; Renic M; Harder DR; Roman RJ
    Am J Physiol Regul Integr Comp Physiol; 2006 Jan; 290(1):R84-9. PubMed ID: 16166205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of 5-hydroxytryptamine1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage.
    Cambj-Sapunar L; Yu M; Harder DR; Roman RJ
    Stroke; 2003 May; 34(5):1269-75. PubMed ID: 12677022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat.
    Kehl F; Cambj-Sapunar L; Maier KG; Miyata N; Kametani S; Okamoto H; Hudetz AG; Schulte ML; Zagorac D; Harder DR; Roman RJ
    Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1556-65. PubMed ID: 11893593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of blood pressure and renal function in chromosome 5 congenic strains of Dahl S rats.
    Roman RJ; Hoagland KM; Lopez B; Kwitek AE; Garrett MR; Rapp JP; Lazar J; Jacob HJ; Sarkis A
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1463-71. PubMed ID: 16396943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a 20-HETE antagonist and agonists on cerebral vascular tone.
    Yu M; Cambj-Sapunar L; Kehl F; Maier KG; Takeuchi K; Miyata N; Ishimoto T; Reddy LM; Falck JR; Gebremedhin D; Harder DR; Roman RJ
    Eur J Pharmacol; 2004 Feb; 486(3):297-306. PubMed ID: 14985052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that 20-HETE contributes to the development of acute and delayed cerebral vasospasm.
    Roman RJ; Renic M; Dunn KM; Takeuchi K; Hacein-Bey L
    Neurol Res; 2006 Oct; 28(7):738-49. PubMed ID: 17164037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of renal arachidonic acid omega-hydroxylase activity with ABT reduces blood pressure in the SHR.
    Su P; Kaushal KM; Kroetz DL
    Am J Physiol; 1998 Aug; 275(2):R426-38. PubMed ID: 9688677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of the 20-HETE inhibitor HET0016 on brain damage after temporary focal ischemia.
    Poloyac SM; Zhang Y; Bies RR; Kochanek PM; Graham SH
    J Cereb Blood Flow Metab; 2006 Dec; 26(12):1551-61. PubMed ID: 16570075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytic cytochrome P450 4A/20-hydroxyeicosatetraenoic acid contributes to angiogenesis in the experimental ischemic stroke.
    Liu Y; Li Y; Zhan M; Liu Y; Li Z; Li J; Cheng G; Teng G; Lu L
    Brain Res; 2019 Apr; 1708():160-170. PubMed ID: 30571981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Novel Pyrazolylpyridine Derivatives for 20-Hydroxyeicosatetraenoic Acid Synthase Inhibitors with Selective CYP4A11/4F2 Inhibition.
    Kawamura M; Kobashi Y; Tanaka H; Bohno-Mikami A; Hamada M; Ito Y; Hirata T; Ohara H; Kojima N; Koretsune H; Gunji E; Fukunaga T; Inatani S; Hasegawa Y; Suzuki A; Takahashi T; Kakinuma H
    J Med Chem; 2022 Nov; 65(21):14599-14613. PubMed ID: 36318660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapy with COX-2 inhibitor and 20-HETE inhibitor reduces colon tumor growth and the adverse effects of ischemic stroke associated with COX-2 inhibition.
    Zhang Y; Hoda MN; Zheng X; Li W; Luo P; Maddipati KR; Seki T; Ergul A; Wang MH
    Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(6):R693-703. PubMed ID: 24990856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.